COVID-19: Optimize Your Health

Florida’s Innovative Response

Florida’s COVID-19 response includes statewide and grassroots initiatives to educate on prevention and treatment of COVID-19.

It is important to stay apprised of your health through routine physicals, cancer screenings, and by communicating with your health care provider.

Staying on track with medical appointments and screenings may help to know your COVID-19 risk level. Individuals who are at higher risk for severe illness, hospitalization, and death include, but are not limited to:

  • Those over 65.
  • Individuals with certain medical conditions.
  • Immunocompromised individuals.


Optimize your health by getting outside, staying active, and eating foods rich in vitamins and nutrients.

Vaccines continue to be widely available in Florida. For more information on eligibility and to find a vaccine near you, visit:

Talk to your health care provider about how certain supplements or foods containing vitamins and minerals might help boost your immune system, such as:

The torso of a doctor holding a stethoscope against a hospital setting with multiple patients and healthcare workers


Monoclonal Antibody Therapy Treatment

Florida was among the first in the nation to significantly expand access to these treatments for both COVID-19 positive and exposed individuals. The Department continues to ensure adequate supply of monoclonal antibody therapy treatment to meet the needs of Florida residents.

Monoclonal antibody therapy treatment can prevent severe illness, hospitalization, and death in high-risk patients who have contracted or been exposed to COVID-19. This treatment has been shown to reduce the risk of hospitalization and death by 70-85% and to reduce the risk of developing symptomatic disease by over 80%.

To find a treatment location near you, visit

A doctor holding a clipboard and consulting a patient seated in a clinic

Emerging Treatments

COVID-19 is a novel disease. Physicians should use their clinical judgment when recommending treatment options for patients’ individualized health care needs. This may include emerging treatment options with appropriate patient informed consent, including off-label use or as part of a clinical trial. For example: